Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Following on from the tragic death of Dr Ling Felce at the Plain roundabout in March 2022, the CAMS-Oxford Institute within the Nuffield Department of Medicine are seeking funds to start an award in her memory.

LingA scientist of extraordinary talent, Ling was able to make the switch from bench scientist to a computational bioinformatician after completing the Oxford Biomedical Data Science Training Programme at the MRC Weatherall Institute of Molecular Medicine. 

The Ling Felce Award seeks to offer financial support for researchers to undertake training in the analysis and interpretation of large datasets. We hope that, in memory of Dr Felce, this award will help support the next generation of world-leading computational biologists.  

Awards will be made to support researchers wishing to sign up to the Oxford Biomedical Data Science Training Programme at the MRC Weatherall Institute of Molecular Medicine.   

To contribute to the fundraising efforts please follow this link. Feel free to share this information with anyone you feel may like to contribute to the fundraising.  

Similar stories

Malaria booster vaccine continues to meet WHO-specified 75% efficacy goal

Researchers from the NDM's Jenner Institute and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of the candidate malaria vaccine, R21/Matrix-M™ – which previously demonstrated high-level efficacy of 77% over the following 12 months in young west African children in 2021.

Oxford spinout MiroBio acquired by Gilead Sciences for $405m

The inflammatory diseases company’s rapid ascent and exit underscores the importance of friendships, partnerships and networks in innovation.

Pandemic Sciences Institute formally launched in Oxford

The University of Oxford’s Pandemic Sciences Institute (PSI) has been formally launched at a two-day event at the Blavatnik School of Government, at which the lead researchers set out its direction and strategy for the next five years.

CAMS Oxford Institute unveiled at virtual ceremony

Oxford University and the Chinese Academy of Medical Sciences (CAMS) signed a cooperation agreement at a virtual unveiling ceremony of the CAMS Oxford Institute.

Turing Fellowship for NDM researcher

Thirty-three University of Oxford researchers have been named Turing Fellows for the 2021/22 academic year, including Dr Benjamin Schuster-Böckler from the Ludwig Institute for Cancer Research.

Moonshot initiative to develop affordable COVID-19 antivirals gets funding boost

The COVID Moonshot, a non-profit, open-science consortium of scientists from around the world dedicated to the discovery of globally affordable and easily-manufactured antiviral drugs against COVID-19 and future viral pandemics has received key funding of £8 million from the Wellcome Trust, on behalf of the Covid-19 Therapeutics Accelerator.